Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

PCNA levels in neuroblastoma are increased in tumors with an amplified N-myc gene and in metastatic stage tumors


N-myc oncogene amplification in neuroblastoma has been found to be significantly associated with advanced stage disease and tumor progression. However, there is a lack of data on tumors, regarding the relationship between N-myc gene amplification and proliferation activity. Proliferating cell nuclear antigen (PCNA) is a proliferation-induced 36 kD nuclear protein that is the auxiliary component of DNA polymerase δ. PCNA levels in tissues have been found to correlate with proliferative activity. We have examined PCNA levels in neuroblastomas in relation to N-myc gene amplification and tumor stage. Statistically, significantly higher levels of PCNA were observed in tumors with an amplified N-myc gene relative to tumors with a single gene copy. The highest levels of PCNA were observed in advanced stage tumors with an amplified N-myc gene. Treatment of neuroblastoma cells in culture with retinoic acid, which induces differentiation, resulted in a substantial decrease in PCNA. Our results suggest that PCNA levels may reflect differences in proliferative activity between neuroblastomas, related to stage of the disease and to N-myc gene copy number.[/p ]

This is a preview of subscription content, log in to check access.


  1. 1.

    Bishop JM, 1991, Molecular themes in oncogenesis.Cell,64, 235–248.

  2. 2.

    Miyachi K, Fritzler MJ and Tan EM, 1978, Autoantibody to a nuclear antigen in proliferation.Journal of Immunology,121, 2228–2234.

  3. 3.

    Mathews MB, Bernstein RM, Franza BR and Garrels JI, 1984, Identity of the proliferating cell nuclear antigen and cyclin.Nature,309, 374–376.

  4. 4.

    Asero R, Origgi L, Crespi S, Bertetti E, D'Agostino P and Riboldi P, 1987, Autoantibody to proliferating cell nuclear antigen (PCNA) in SLE: a clinical and serological study.Clinical and Experimental Rheumatology,5, 241–246.

  5. 5.

    Celis JE, Madsen P, Celis A, Nielsen HV and Gesser B, 1987, Cyclin (PCNA, auxiliary protein of DNA polymerase δ) is a central component of the pathway(s) leading to DNA replication and cell division.FEBS Letters,220, 1–7.

  6. 6.

    Bravo R, 1986, Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication.Experimental Cell Research,163, 287–293.

  7. 7.

    Kurki P, Lotz M, Ogata K and Tan EM, 1987, Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes.Journal of Immunology,138, 4114–4120.

  8. 8.

    Ogata K, Celis JE and Tan EM, 1987, Proliferating cell nuclear antigen: cyclin.Methods in Enzymology,150, 147–159.

  9. 9.

    Bravo R and Celis JE, 1980, A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells.Journal of Cell Biology,84, 795–802.

  10. 10.

    Jaskulski D, DeRiel JK, Mercer WE, Calabretta B and Baserga R, 1988, Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin.Science,240, 1544–1546.

  11. 11.

    Robbins BA, de la Vega D, Ogata K, Tan EM and Nakamura RM, 1987, Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies.Archives of Pathology and Laboratory Medicine 111, 841–845.

  12. 12.

    Takasaki Y, Robinson WA and Tan EM, 1984, Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.Journal of the National Cancer Institute,73, 655–661.

  13. 13.

    Keim D, Hailat N, Hodge D and Hanash SM, 1990, Proliferating cell nuclear antigen expression in childhood acute leukemia.Blood,76, 985–990.

  14. 14.

    Brodeur GM, Seeger RC, Schwab M, Varmus HE and Bishop JM, 1984, Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.Science,224, 1121–1124.

  15. 15.

    Schwab M, Ellison J, Busch M, Rosenau W, Varmus HE and Bishop JM, 1984, Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma.Proceedings of the National Academy of Sciences, USA,81, 4940–4944.

  16. 16.

    Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY and Hammond D, 1985, Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma.New England Journal of Medicine,313, 1111–1116.

  17. 17.

    Tsuda T, Obara M, Hirano H, Gotoh S, Kubomura S, Higashi K, Kuroiwa A, Nakagawara A, Nagahara N and Shimizu K, 1987, Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas.Cancer,60, 820–826.

  18. 18.

    Grady-Leopard EF, Schwab M, Ablin AR and Rosenau W, 1986, Detection of N-myc oncogene expression in human neuroblastoma byin situ hybridization blot analysis: relationships to clinical outcome.Cancer Research,46, 3196–3199.

  19. 19.

    Koop CE and Johnson DG, 1971, Neuroblastoma: an assessment of therapy in reference to staging.Journal of Pediatric Surgery,6, 595–600.

  20. 20.

    Evans AE, Albo V, D'Angio GJ, Finklestein JZ, Leiken S, Santalli T, Weiner J and Hammond GD, 1976, Factors influencing survival of children with non-metastatic neuroblastoma.Cancer,38, 661–666.

  21. 21.

    Breslow N and McCann B, 1971, Statistical estimation of prognosis for children with neuroblastoma.Cancer Research,31, 2098–2103.

  22. 22.

    Phillips WS, Stafford PW, Duvol-Arnold B and Ghosh BC, 1991, Neuroblastoma and the clinical significance of N-myc oncogene amplification.Surgical Gynecology and Obstetrics,172, 73–80.

  23. 23.

    Hailat N, Keim DR, Melhem RF, Zhu X-X, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR and Hanash SM, 1991, High levels of P19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification.Journal of Clinical Investigations,88, 341–345.

  24. 24.

    Hailat N, Strahler J, Melhem R, Zhu X-X, Brodeur G, Seeger RC, Reynolds CP and Hanash SM, 1990, N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Opl8).Oncogene,5, 1615 -1618.

  25. 25.

    Sidell N, Altmann A, Haussler MR and Seeger RC, 1983, Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuro blastoma cell lines.Experimental Cell Research,148, 21–30.

  26. 26.

    Thiele CJ, Reynolds CP and Israel MA, 1985, Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma.Nature,313, 404–406.

  27. 27.

    Strahler JR, Kuick R and Hanash SM. Two-dimensional polyacrylamide gel electrophoresis of proteins. In: Creighton T, ed.Protein Structure: a practical approach, pp. 65–92. Oxford: IRL Press, 1989.

  28. 28.

    Merril CR, Goldman D, Sedman SA and Ebert MA, 1981, Ultrasensitive stain for proteins in polyacrylamide gels show regional variation in cerebrospinal fluid.Science,211, 1437–1438.

  29. 29.

    Kuick R, Hanash SM, Chu EHY and Strahler JR, 1987, A comparison of some adjustment techniques for use with quantitative spot data.Electrophoresis,8, 199–204.

  30. 30.

    Ogata K, Kurki P, Celis JE, Nakamura RM and Tan EM, 1987, Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication.Experimental Cell Research,168, 475–486.

  31. 31.

    Haskell BF, Stach RW, Werrbach-Perez K and Perez-Polo JR, 1987, Effect of retinoic acid on nerve growth factor receptors.Cell Tissue Research,247, 67–73.

  32. 32.

    Willnow V, 1979, The kinetics of cell proliferation in neuroblastoma.Archiv fur Geschwulstforschung,49, 211–219.

  33. 33.

    Wagner HP and Kaser H, 1970, Cell proliferation in neuroblastoma.European Journal of Cancer,6, 369–372.

  34. 34.

    Tay DLM, Bhathal PS and Fox RM, 1990, Quantitation of G0 and G1 phase cells in primary carcinomas.Journal of Clinical Investigations,87, 519–527.

  35. 35.

    Cohn SL, Rademaker AW, Salwen HR, Franklin WA, Gonzales-Crussi F, Rosen ST and Bauer KD, 1990, Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.American Journal of Pathology,136, 1043–1052.

  36. 36.

    Cohn SL, Salwen H, Quasney MW, Ikegaki N, Cowan JM, Herst CV, Kennett RH, Rosen ST, DiGuisseppe JA and Brodeur GM, 1990, Prolonged N-myc protein half life in a neuroblastoma cell line lacking N-myc amplification.Oncogene,5, 1821–1827.

  37. 37.

    Hammerling U, Bjelfman C and Pahlman S, 1987, Different regulation of N- and c-myc expression during phorbol ester-induced maturation of human SH-SYSY neuroblastoma cells.Oncogene,2, 73–77.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Keim, D.R., Hailat, N., Kuick, R. et al. PCNA levels in neuroblastoma are increased in tumors with an amplified N-myc gene and in metastatic stage tumors. Clin Exp Metast 11, 83–90 (1993). https://doi.org/10.1007/BF00880069

Download citation


  • metastasis
  • neuroblastoma
  • oncogene